In the conversation, Bryce explores how DiaDeep’s biomarker quantification tools are being integrated into the Aperio AI Store, helping laboratories access specialised AI applications through a single digital pathology workflow. He also discusses the Store’s flexible approach to licensing and its growing ecosystem of AI partners.

Looking ahead, the discussion considers how Leica Biosystems is working to move AI beyond proof-of-concept and into practical, routine pathology workflows, with a focus on accessibility, integration and supporting pathologists as AI adoption continues to grow.